Edition:
United Kingdom

Aslan Pharmaceuticals Ltd (ASLN.OQ)

ASLN.OQ on NASDAQ Stock Exchange Global Market

7.30USD
12 Oct 2018
Change (% chg)

$-0.00 (-0.00%)
Prev Close
$7.30
Open
$7.39
Day's High
$7.39
Day's Low
$7.30
Volume
1,962
Avg. Vol
4,252
52-wk High
$10.41
52-wk Low
$5.08

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Jun '18 0.00 -2.233
Mar '18 0.00 -1.959
FY 2017 Dec '17 0.00 -3.358
Sep '17 0.00 -1.851
Jun '17 0.00 -2.299
Mar '17 0.00 -2.169
FY 2016 Dec '16
Dec '16 0.00
Sep '16 324.24 1.429
Jun '16 8.21 -8.853
 
*Note: Units in Millions ofTaiwanese Dollars
**Note: Units in Taiwanese Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Year Ending Dec-18 1 0.00 0.00 0.00 --
Year Ending Dec-19 1 0.00 0.00 0.00 --
Earnings (per share)
Year Ending Dec-18 1 -8.18 -8.18 -8.18 --
Year Ending Dec-19 1 -11.39 -11.39 -11.39 --
Sales and Profit Figures in Taiwanese Dollar (TWD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 30.89 32.75
P/E High - Last 5 Yrs. -- 40.53 45.42
P/E Low - Last 5 Yrs. -- 23.69 24.25
Beta -- 0.90 0.89
Price to Sales (TTM) 15.98 3.93 5.74
Price to Book (MRQ) 3.32 4.88 5.00
Price to Tangible Book (MRQ) 3.32 5.70 6.57
Price to Cash Flow (TTM) -- 22.85 23.28
% Owned Institutions -- 1.18 2.26

Dividends

  Company industry sector
Dividend Yield -- 1.57 1.51
Dividend Yield - 5 Year Avg -- 1.58 1.52
Dividend 5 Year Growth Rate -- 4.36 5.24
Payout Ratio(TTM) -- 45.77 43.77

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -100.00 2.26 8.00
Sales (TTM) vs TTM 1 Yr. Ago 4,341.80 4.76 5.62
Sales - 5 Yr. Growth Rate -- 9.94 10.18
EPS (MRQ) vs Qtr. 1 Yr. Ago -104.48 17.63 20.60
EPS (TTM) vs TTM 1 Yr. Ago 81.78 -- --
EPS - 5 Yr. Growth Rate -- 9.75 10.66
Capital Spending - 5 Yr. Growth Rate -- 15.39 15.33

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.15 2.22
Current Ratio (MRQ) 18.10 2.94 3.03
LT Debt to Equity (MRQ) 15.50 9.99 12.55
Total Debt to Equity (MRQ) 15.50 14.03 16.89
Interest Coverage (TTM) -15.86 35.81 32.71

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 54.71 54.34
Gross Margin - 5 Yr. Avg. -- 52.10 52.13
EBITD Margin (TTM) -156.26 -- --
EBITD - 5 Yr. Avg -- 18.50 10.68
Operating Margin (TTM) -157.49 14.33 4.33
Operating Margin - 5 Yr. Avg. -- 14.46 6.11
Pre-Tax Margin (TTM) -160.59 14.83 5.20
Pre-Tax Margin - 5 Yr. Avg. -- 14.87 6.52
Net Profit Margin (TTM) -160.59 11.08 1.49
Net Profit Margin - 5 Yr. Avg. -- 11.17 2.79
Effective Tax Rate (TTM) -- 23.21 23.12
Effective Tax Rate - 5 Yr. Avg. -- 23.49 23.98

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 953,546,407 859,711,668
Net Income/Employee (TTM) -- 112,184,475 101,129,378
Receivable Turnover (TTM) 89.37 5.72 5.87
Inventory Turnover (TTM) -- 2.63 3.41
Asset Turnover (TTM) 0.19 0.96 0.94

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -30.40 11.59 11.13
Return on Assets - 5 Yr. Avg. -- 12.95 12.40
Return on Investment (TTM) -31.58 15.08 14.60
Return on Investment - 5 Yr. Avg. -- 16.91 16.13
Return on Equity (TTM) -37.22 16.60 16.33
Return on Equity - 5 Yr. Avg. -- 17.98 17.39
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 92.11 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Aslan Pharmaceuticals Ltd

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 2.15%
# of Holders: 4
Total Shares Held: 3,445,600
3 Mo. Net Change: 101,000
# New Positions: 0
# Closed Positions: 0
# Increased Positions: 1
# Reduced Positions: 0
# Net Buyers: 1
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.